Consumer Lawsuits / Class Action News

Monsanto to Pay $289.2 Million in Landmark Roundup Lawsuit Verdict

August 10, 2018 San Francisco, California - - A San Francisco jury returned a verdict today in the case of a former groundskeeper with terminal cancer against Monsanto Company, ordering the agrochemical giant to pay $39.2 million in compensatory damages and $250 million in punitive damages for failing to warn [...]

Johnson & Johnson to Pay $4.69 Billion in Largest Talcum Powder Verdict

Johnson & Johnson to Pay $4.69 Billion in Largest Talcum Powder VerdictJuly 13, 2018 – St. Louis, Missouri - - A St. Louis jury held that Johnson & Johnson (J&J) talc products contained asbestos and caused cancer in 22 women, slamming the multinational health products company with a landmark $4.69 billion [...]

By | 2018-07-16T10:39:09+00:00 July 13th, 2018|Talcum Powder News|

CA Jury Issues $25.75 Million Talcum Powder Verdict Against J&J

May 25, 2018 – Los Angeles, California - - A California jury issued a $25.75 million talcum powder verdict against Johnson & Johnson (J&J) this morning, siding with an Oregon woman who claimed that her cancer was caused by J&J baby powder. This case is just one of the many [...]

Johnson & Johnson Loses Another Mega-Million Baby Powder Trial

A New Jersey state court jury has returned verdicts totaling $117 million against Johnson & Johnson and its talc supplier, Imerys Talc America Inc., after finding that the healthcare giant’s talcum powder caused a New Jersey man to develop mesothelioma. The award included $37 million in compensatory damages to plaintiffs [...]

By | 2018-05-02T19:51:11+00:00 April 20th, 2018|Talcum Powder News, Consumer Lawsuits / Class Action News|

Researchers Seek Retraction of MD-18 Celexa Study

Feb. 23, 2018 – Los Angeles, California – A group of researchers sent a letter this week to Dr. Robert Freedman, Editor of the American Journal of Psychiatry, calling for the retraction of a Celexa study the researchers claim is rife with “serious misrepresentations.” The study, known as the MD-18 ‘Wagner’ [...]

Johnson & Johnson Fraud Lawsuit Filed Over Asbestos in Baby Powder

On February 8, 2018, a federal securities class action lawsuit against J&J was filed, charging the company with defrauding investors by failing to disclose the presence of asbestos and heavy metals in its baby powder products. The suit was filed in the United States District Court for the District of New [...]

By | 2018-05-02T07:29:49+00:00 February 15th, 2018|Talcum Powder News, Consumer Lawsuits / Class Action News|

Baum Hedlund Urges DOJ to Reopen Investigation re Celexa / Lexapro Clinical Trials

Boston, Massachusetts – February 8, 2018 - - The law firm of Baum, Hedlund, Aristei & Goldman has sent a letter and memorandum to the U.S. Attorney’s Office (USAO) for the District of Massachusetts calling for the reopening of its investigation and prosecution of Forest Laboratories Inc. and its subsidiary, [...]

Judge Upholds $110M Talc Verdict, Paves Way for Out of State Cases

Dec. 6, 2017 – St. Louis, Missouri -- A Missouri judge decided to uphold a $110 million verdict against Johnson & Johnson (J&J) in a lawsuit filed by a Virginia woman who says she developed ovarian cancer after using J&J talcum powder products for feminine hygiene. The Nov. 29 ruling [...]

By | 2018-01-04T16:04:40+00:00 December 6th, 2017|Talcum Powder News|

Talcum Powder Documents at Center of Johnson & Johnson Cancer Lawsuits

More than 2,000 women who have sued health care giant Johnson & Johnson, claiming the company’s baby powder causes ovarian cancer, have won an important legal battle in ongoing multidistrict litigation in the U.S. District Court for the District of New Jersey. At issue were documents subpoenaed by the plaintiffs [...]

By | 2018-01-04T14:05:51+00:00 November 7th, 2017|Talcum Powder News|

Acthar Class Action Accuses Mallinckrodt of Inflating Price 85,000%

Los Angeles, California - - A class action lawsuit filed on behalf of numerous Medicare Advantage Organizations (MAOs) accuses pharmaceutical manufacturer Mallinckrodt (MNK) of engaging in a scheme to drastically inflate the price and reduce competition for its drug H.P. Acthar Gel (Acthar), a drug primarily prescribed for infants with [...]